Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuroscience Letters

• Publication date

  2007-04-24

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.NEULET.2007.01.017PMID 17386975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene Expression in Blood Changes Rapidly in Neutrophils and Monocytes after Ischemic Stroke in Humans: A Microarray Study

  2006cited by this paper
• Experimental Stroke Induces Massive, Rapid Activation of the Peripheral Immune System

  2006cited by this paper
• Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke

  2006cited by this paper
• Two-way interactions between inflammation and coagulation.

  2005cited by this paper
• Tissue plasminogen activator and glial function

  2005cited by this paper
• Superoxide Dismutase 1 Overexpression Reduces MCP-1 and MIP-1α Expression after Transient Focal Cerebral Ischemia

  2005cited by this paper
• tPA and proteolysis in the neurovascular unit.

  2004cited by this paper
• Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator

  2003cited by this paper
• Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases

  2002cited by this paper
• Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury.

  2002cited by this paper
• Matrix metalloproteinases in neuroinflammation

  2002cited by this paper
• Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia‐reperfusion brain injury in the rat

  2002cited by this paper
• The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling

  2001cited by this paper
• Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke

  2001cited by this paper
• Serine Protease Inhibitors: Novel Therapeutic Targets for Stroke?

  2000cited by this paper
• Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin.

  1997cited by this paper
• Inhibition of Tumor Necrosis Factor and Amelioration of Brain Infarction in Mice

  1997cited by this paper
• Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper

• Tissue plasminogen activator rescues steroid-induced outflow facility reduction via non-enzymatic action

  2021cites this paper
• The ectoenzyme-side of matrix metalloproteinases (MMPs) makes inflammation by serum amyloid A (SAA) and chemokines go round.

  2019cites this paper
• Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus

  2019cites this paper
• [VEGF-A therapeutic target against hemorrhagic transformation after t-PA treatment].

  2019cites this paper
• Post-synaptic Release of the Neuronal Tissue-Type Plasminogen Activator (tPA)

  2019cites this paper
• The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?

  2019cites this paper
• Selective knockout of astrocytic Na+/H+ exchanger isoform 1 reduces astrogliosis, BBB damage, infarction, and improves neurological function after ischemic stroke

  2018cites this paper
• The two faces of pannexins: new roles in inflammation and repair

  2018cites this paper
• Trafic neuronal de l’activateur tissulaire du plasminogène (tPA)

  2018cites this paper
• Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway

  2017cites this paper
• Pathogenesis of AAA Rupture

  2017cites this paper
• Epsilon Aminocaproic Acid Pretreatment Provides Neuroprotection Following Surgically Induced Brain Injury in a Rat Model.

  2016cites this paper
• Low density lipoprotein receptor-related protein 1 mediated endocytosis of β1-integrin influences cell adhesion and cell migration.

  2016cites this paper
• Glial Support of Blood–Brain Barrier Integrity: Molecular Targets for Novel Therapeutic Strategies in Stroke

  2016cites this paper
• Increased 18F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model.

  2015cites this paper
• Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression.

  2015cites this paper
• Increased 18F-FDG Uptake Is Predictive of Rupture in a Novel Rat Abdominal Aortic Aneurysm Rupture Model

  2015cites this paper
• Neuronal and astrocytic interactions modulate brain endothelial properties during metabolic stresses of in vitro cerebral ischemia

  2014cites this paper
• Recombinant Tissue Plasminogen Activator Enhances Microglial Cell Recruitment after Stroke in Mice

  2014cites this paper
• The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier

  2014cites this paper
• CNS Barriers in Neurotrauma

  2014cites this paper
• Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.

  2014cites this paper
• Pathogenesis and reversal of liver fibrosis: Effects of genes and environment

  2013cites this paper
• Fasting reduces liver fibrosis in a mouse model for chronic cholangiopathies.

  2013cites this paper
• Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke.

  2013cites this paper
• TIMP-1 attenuates blood–brain barrier permeability in mice with acute liver failure

  2013cites this paper
• Therapeutic benefits from nanoparticles: the potential significance of nanoscience in diseases with compromise to the blood brain barrier.

  2013cites this paper
• Hemostasis and Alterations of the Central Nervous System

  2013cites this paper
• Molecular Mechanisms of MMP9 Expression in Astrocytes Induced by Heme and Iron

  2012cites this paper
• Hyperthermia worsens ischaemic brain injury through destruction of microvessels in an embolic model in rats

  2012influential citation
• Endothelial Cells and Astrocytes: A Concerto en Duo in Ischemic Pathophysiology

  2012cites this paper
• Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.

  2012cites this paper
• Albumin induces upregulation of matrix metalloproteinase-9 in astrocytes via MAPK and reactive oxygen species-dependent pathways

  2012cites this paper
• Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

  2012cites this paper
• [Dysfunction of the blood-brain barrier during ischaemia: a therapeutic concern].

  2012cites this paper
• Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.

  2012cites this paper
• Plasminogen Activators in Ischemic Stroke

  2012cites this paper
• La barrière hémato-encéphalique lors de l’ischémie cérébrale : une cible thérapeutique

  2012cites this paper
• Impaired fibrinolytic system in ApoE null mice with hyperlipidemia augments deep vein thrombosis

  2012cites this paper
• Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA.

  2011cites this paper
• Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment

  2011cites this paper
• The Effect of Tissue Plasminogen Activator on TGF-β1 Pre-Treated Human Mesothelial Cell Line

  2011cites this paper
• Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1.

  2011cites this paper
• [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation].

  2011cites this paper
• Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage.

  2010cites this paper
• Presence of secretory cellular apoptosis susceptibility protein in cerebrospinal fluids of patients with intracerebral hemorrhage caused by stroke and neurotrauma.

  2010cites this paper
• The Contribution of L-Arginine to the Neurotoxicity of Recombinant Tissue Plasminogen Activator following Cerebral Ischemia: A Review of rtPA Neurotoxicity

  2010cites this paper
• Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases.

  2010cites this paper
• Intracerebroventricular administration of an endothelin ET(B)-receptor agonist increases expression of matrix metalloproteinase-2 and -9 in rat brain.

  2010cites this paper
• The Role of Zinc in Neuronal Injury and Death in an Oxygen-Glucose Deprivation Model of Ischemic Stroke

  2010cites this paper
• Role of CX3CL1 in Synaptic Activity and Neuroprotection

  2010cites this paper
• Increasing tPA Activity in Astrocytes Induced by Multipotent Mesenchymal Stromal Cells Facilitate Neurite Outgrowth after Stroke in the Mouse

  2010cites this paper
• Blood–Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9

  2010cites this paper
• Signaling, delivery and age as emerging issues in the benefit/risk ratio outcome of tPA For treatment of CNS ischemic disorders

  2010cites this paper
• Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic.

  2009cites this paper
• Synaptic Mechanisms of Activity-Dependent Remodeling in Visual Cortex during Monocular Deprivation

  2009cites this paper
• Prognostic Value of Tumor-Related Molecular Expression in Gastric Carcinoma

  2009cites this paper
• Identification of regulatory Hck and PAI-2 proteins in the monocyte response to PEG-containing matrices.

  2009cites this paper
• Use of selenium to detect mercury in water and cells: an enhancement of the sensitivity and specificity of a seleno fluorescent probe.

  2009cites this paper
• Microglial Low-Density Lipoprotein Receptor-Related Protein 1 Mediates the Effect of Tissue-Type Plasminogen Activator on Matrix Metalloproteinase-9 Activity in the Ischemic Brain

  2009influential citation
• Dissociation and Protection of the Neurovascular Unit after Thrombolysis and Reperfusion in Ischemic Rat Brain

  2009cites this paper
• Biomarcadores plasmaticos en la enfermedad vascular cerebral isquemica

  2009cites this paper
• Prior statin use, intracranial hemorrhage, and outcome after intra-arterial thrombolysis for acute ischemic stroke.

  2009cites this paper
• Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.

  2009cites this paper
• Differential Regulation of Matrix Metalloproteinase-9 and Tissue Plasminogen Activator Activity by the Cyclic-AMP System in Lipopolysaccharide-stimulated Rat Primary Astrocytes

  2008cites this paper
• Post traumatic lesion absence of beta-dystroglycan-immunopositivity in brain vessels coincides with the glial reaction and the immunoreactivity of vascular laminin.

  2008cites this paper
• Protocatechuic acid from Alpinia oxyphylla promotes migration of human adipose tissue-derived stromal cells in vitro.

  2008cites this paper
• A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis.

  2007cites this paper